Child mortality according to maternal and infant HIV status in Zimbabwe

Pediatric Infectious Disease Journal

Volumn 26, Issue 6, 2007, Pages 519-526

  Marinda, Edmore ^a   Humphrey, Jean H ^a,b   Iliff, Peter J ^a   Mutasa, Kuda ^a   Nathoo, Kusum J ^c   Piwoz, Ellen G ^d   Moulton, Lawrence H ^b   Salama, Peter ^e   Ward, Brian J ^f   Chidawanyika, Henry ^g   Hargrove, John ^g   Mahomva, Agnes ^g   Majo, Florence ^g   Malaba, Lucie ^g   Mbizvo, Michael ^g   Mzengeza, Faith ^g   Nathoo, Kusum ^g   Ndhlovu, Mary ^g   Ntozini, Robert ^g   Propper, Lidia ^g   Rambanepasi, Philipa ^g   Ruff, Andrea ^g   Tavengwa, Naume ^g   Zijenah, Lynn ^g   Zunguza, Claire ^g   Zvandasara, Partson ^g   more..

^a ZVITAMBO Project   (Zimbabwe)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^d FAMILY HEALTH INTERNATIONAL   (United States)

^e UNICEF   (United States)

^f MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^g NONE

Author keywords

Child mortality; HIV; Maternal HIV status; Time of infection

Indexed keywords

ARTICLE; CAUSE OF DEATH; CHILDHOOD MORTALITY; FEMALE; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INTRAUTERINE INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; VERTICAL TRANSMISSION; ZIMBABWE;

ADOLESCENT; ADULT; CAUSE OF DEATH; CHILD MORTALITY; CHILD, PRESCHOOL; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFANT MORTALITY; INFANT, NEWBORN; MALE; PREGNANCY; RESPIRATORY TRACT INFECTIONS; RISK FACTORS; TIME FACTORS; ZIMBABWE;

EID: 34249815211     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000264527.69954.4c     Document Type: Article

References (29)

1. UNAIDS. Report on the Global HIV/AIDS Epidemic, 05/19E ed. Geneva, Switzerland, 2005.
2. Newell ML, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, Dabis F. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet. 2004;364:1236-1243.
3. Malaba LC, Iliff PJ, Nathoo KJ, et al. Effect of postpartum maternal or neonatal vitamin A supplementation on infant mortality among infants born to HIV-negative mothers in Zimbabwe. Am J Clin Nutr. 2005;81:454-460.
4. Humphrey JH, Iliff PJ, Marinda E, et al. Effects of a single large dose of vitamin A, given during the postpartum period to HIV-positive women and their infants, on child HIV infection, HIV-free survival, and mortality. J Infect Dis. 2006;193:860-871.
5. Humphrey JH, Hargrove JW, Malaba LC, et al. HIV incidence among postpartum women in Zimbabwe: risk factors and the effect of vitamin A supplementation. AIDS. 2006;20:1437-1446.
6. Iliff PJ, Piwoz EG, Tavengwa NV, et al. Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival. AIDS. 2005;19:699-708.
7. Deleted in proof.
8. Piwoz EG, Iliff PJ, Tavengwa NV, et al. An education and counseling program for preventing breastfeeding-associated HIV transmission in Zimbabwe: design and impact on maternal knowledge and behaviour. J Nutr. 2005;135:950-955.
9. Miller MF, Humphrey JH, Iliff PJ, Malaba LC, Mbuya NV, Stoltzfus RJ. Neonatal erythropoiesis and subsequent anemia in HIV-positive and HIV-negative Zimbabwean babies during the first year of life: a longitudinal study. BMC Infect Dis. 2006;6:1.
10. World Health Organization. The measurement of overall and cause-specific mortality in infants and children. Report of a Joint WHO/UNICEF Consultation; December 15-17, 1992; Geneva, Switzerland.
11. World Health Organization, UNAIDS. Provisional WHO/UNAIDS recommendations on the use of co-trimoxazole prophylaxis in adults and children living with HIV/AIDS in Africa. Afr Health Sci. 2001;1:30-31.
12. Capurro H, Konichezky S, Fonseca D, et al. A simplified method for diagnosis of gestational age in the newborn infant. J Pediatr. 1978;93:120-122.
13. Gibson RS. Nutrition Assessment: A Laboratory Manual. New York: Oxford University Press; 1993.
14. Piwoz EG, Humphrey JH, Marinda E, et al. Effects of infant sex on mother-to-child transmission of HIV-1 according to timing of infection in Zimbabwe. AIDS. 2006;20:1981-1984.
15. Simonds RJ, Oxtoby MJ, Caldwell MB, Gwinn ML, Rogers MF. Pneumocystis carinii pneumonia among US children with perinatally acquired HIV infection. JAMA. 1993;270:470-473.
16. Graham SM, Mtitimila EI, Kamanga HS, Walsh AL, Hart CA, Molyneux ME. Clinical presentation and outcome of Pneumocystis carinii pneumonia in Malawian children. Lancet. 2004;355:369-373.
17. Chokephaibulkit K, Wanachiwanawin D, Chearskul S, et al. Pneumocystis carinii severe pneumonia among human immunodeficiency virus-infected children in Thailand: the effect of a primary prophylaxis strategy. Pediatr Infect Dis J. 1999;18:147-152.
18. Zar HJ, Dechaboon A, Hanslo D, Apolles P, Magnus KG, Hussey G. Pneumocystis carinii pneumonia in South African children infected with human immunodeficiency virus. Pediatr Infect Dis J. 2000;19:603-607.
19. Ruffini DD, Madhi SA. The high burden of Pneumocystis carinii pneumonia in African HIV-1-infected children hospitalized for severe pneumonia. AIDS. 2002;16:105-112.
20. WHO. WHO expert consultation on co-trimoxazole prophylaxis in HIV infection. Report of a WHO Expert Consultation; May 10-12, 2005; Geneva, Switzerland.
21. The European Collaborative Study. Fluctuations in symptoms in human immunodeficiency virus-infected children: the first 10 years of life. Pediatrics. 2001;108:116-122.
22. Graham SM. Prophylaxis against Pneumocystis carinii pneumonia for HIV-exposed infants in Africa. Lancet. 2002;360:1966-1968.
23. World Health Organisation. Antiretroviral Therapy of HIV Infection in Infants and Children in Resource-Limited Settings: Towards Universal Access: Recommendations for a Public Health Approach. Geneva, Switzerland: WHO; 2006.
24. Berk DR, Falkovitz-Halpern MS, Hill DW, et al. Temporal trends in early clinical manifestations of perinatal HIV infection in a population-based cohort. JAMA. 2005;293:2221-2231.
25. Chiappini E, Galli L, Tovo PA, et al. Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection. AIDS. 2006;20:207-215.
26. Kuhn L, Kasonde P, Sinkala M, et al. Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants. Clin Infect Dis. 2005;41:654-661.
27. Spira R, Lepage P, Msellati P, et al. Natural history of human immunodefiency virus type 1 infection in children: a five-year prospective study in Rwanda. Pediatrics. 1999;104:1-9.
28. Chearskul S, Chotpitayasunondh T, Simonds RJ, et al. Survival, disease manifestations, and early predictors of disease progression among children with perinatal human immunodeficiency virus infection in Thailand. Pediatrics. 2002;110:1-6.
29. Farquhar C, Nduati R, Haigwood N, et al. High maternal HIV-1 viral load during pregnancy is associated with reduced placental transfer of measles IgG Antibody. J Acquir Immune Defic Syndr. 2005;40:494-497.